Clinical application of artificial liver and blood purification: expert consensus recommendations

Hepatol Int. 2023 Feb;17(1):4-17. doi: 10.1007/s12072-022-10430-8. Epub 2022 Nov 2.

Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association:
An Jihong, Bai Han, Chen Jing, Cheng Jilin, Dai Fei, Ding Yang, Dong Yuwei, Fu Na, Gao Yi, Geng Jiawei, Gong Xiaobing, Huang Yan, Huang Yuan, Huo Xiaolin, Jin Qinglong, Li Hai, Li Jun, Li Shuchen, Li Wu, Li Ying, Lu Gaofeng, Lu Haiying, Lu Qinghua, Luo Xinhua, Mao Xiaorong, Sheng Huiping, Wang Lei, Wu Xiaoping, Ye Feng, Zhang Yuexin, Zheng Xin, Zhou Xinmin, Zou Huaibin, Zuo Weize

¹ Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. chybeyondl071@ccmu.edu.cn.
² Department of Gastroenterology and Hepatology, Tianjin Union Medical Center Affiliated to Nankai University, Tianjin, 300121, China. hantaomd@126.com.
³ Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. duan@ccmu.edu.cn.

No abstract available

MeSH terms